Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31220431 | 0.99 | NPC1 (0.34) | NPC1MAPTHTTRAB9ASMN1; SMN2 | |
| SCHEMBL28337547 | 0.80 | NPC1 (0.36) | NPC1MAPTHTTRAB9ASMN1; SMN2 | |
| SCHEMBL370869 | 0.71 | FFAR1 (0.36) | FFAR1 | |
| SCHEMBL28809235 | 0.69 | USP30 (0.33) | USP30NR1H2NR1H3FFAR1 | |
| SCHEMBL29267550 | 0.65 | FFAR1 (0.40) | FFAR1 | |
| SCHEMBL22900831 | 0.65 | USP30 (0.43) | MAPTUSP30 | |
| SCHEMBL28995960 | 0.64 | SMN1; SMN2 (0.44) | NPC1MAPTHTTRAB9ASMN1; SMN2 | |
| SCHEMBL29267551 | 0.64 | FFAR1 (0.34) | FFAR1 | |
| SCHEMBL28633833 | 0.64 | HPGD (0.39) | NPC1MAPTHTTRAB9ASMN1; SMN2 | |
| SCHEMBL28481380 | 0.64 | ALDH1A1 (0.62) | NPC1MAPTHTTRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114787160-A | Imidazopyridazines and imidazopyridines as activin receptor-like kinase-2 inhibitors | 因赛特公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-111349083-A | Palladium removal method for crizotinib intermediate | 江苏万邦生化医药集团有限责任公司 | 2020-06-30 | — | — | CN | disclosed |
| CN-111171021-A | Tropomyosin-related kinase (TRK) inhibitors | 建新公司 | 2020-05-19 | — | — | CN | disclosed |
| CN-106232597-B | Tropomyosin-related kinase (TRK) inhibitors | 建新公司 | 2019-12-17 | — | — | CN | disclosed |